Craft

Terumo Aortic

Revenue

£88.2 M

FY, 2021

Terumo Aortic Summary

Company Summary

Overview
Terumo Aortic is a company that provides medical devices for the treatment of aortic and peripheral vascular disease. It offers surgical grafts, hybrid grafts, and catheter-based stent graft systems and includes the treatment for thoracic, abdominal and peripheral aneurysms, acute and chronic dissections, and peripheral occlusions.
Type
Subsidiary
Status
Active
Founded
1982
HQ
Inchinnan, GB | view all locations
Website
https://terumoaortic.com/
Cybersecurity rating
Sectors

Key People

  • Erik Pomp

    Erik Pomp, Chief Executive Officer

  • Mark Miles

    Mark Miles, Chief Commercial Officer

  • John Canning

    John Canning, Chief Technology Officer

  • Paul Holbrook

Operating MetricsView all

Product Complaints per Sales, percent

0.1%
50.0%

FY, 2021

Patents Issued

1

Jul, 2022

Trademarks and Trademark Applications

90

Jul, 2022

LocationsView all

2 locations detected

  • Inchinnan, Scotland HQ

    United Kingdom

    Newmains Ave

  • Sunrise, FL

    United States

    799 International Pkwy

Terumo Aortic Financials

Summary Financials

Revenue (FY, 2021)
£88.2M
Gross profit (FY, 2021)
£45.4M
Net income (FY, 2021)
£11.4M
Cash (FY, 2021)
£15.9M
EBIT (FY, 2021)
£13.9M

Footer menu